Abacus Global Management's lawsuit against Coventry First proceeds after the court denies Coventry's motion to dismiss defamation claims.
Quiver AI Summary
Abacus Global Management, Inc. announced a significant legal victory after a federal court allowed its lawsuit against Coventry First LLC and its Chairman, Alan Buerger, to proceed. The court found that Abacus made plausible claims of defamation and anticompetitive behavior, denying Coventry’s motion to dismiss the case. Abacus claims that Coventry conducted a years-long campaign to spread false information to damage its reputation and market position. Following this ruling, depositions of Coventry executives, including Buerger, will move forward. Abacus is seeking hundreds of millions in damages, aiming to address the financial injuries caused by Coventry's alleged deceptive practices. CEO Jay Jackson emphasized that the ruling validates their claims and allows them to uncover the truths behind Coventry’s actions.
Potential Positives
- Abacus achieved a favorable ruling from the U.S. District Court, which allows the lawsuit against Coventry to proceed, enhancing its opportunity to seek justice and damages for alleged defamation and anticompetitive conduct.
- The court's decision confirms the credibility of Abacus's claims regarding a systematic campaign by Coventry to disseminate false information, reinforcing Abacus’s position in the market.
- CEO Jay Jackson's statement underscores Abacus's competitive advantage in terms of pricing and transparency, which may strengthen investor confidence and public perception.
- Abacus is pursuing hundreds of millions in damages, which could significantly benefit the company financially and bolster its reputation if successful.
Potential Negatives
- The court ruling indicates that Abacus has plausibly alleged a scheme against it, which may cast a shadow on its reputation and operational integrity amid ongoing litigation.
- The necessity for depositions from the Chairman and executive team of Coventry suggests that Abacus could face further scrutiny and public exposure of potentially damaging information during the legal proceedings.
- Abacus is seeking hundreds of millions in damages due to alleged reputational harms, highlighting significant financial risks and uncertainties regarding its market position and investor confidence.
FAQ
What was the court's ruling regarding Abacus's lawsuit against Coventry?
The court found that Abacus plausibly alleged defamation and allowed the lawsuit to proceed.
What claims does Abacus's lawsuit make against Coventry?
Abacus alleges defamation and anticompetitive conduct aimed at damaging its reputation and market position.
Who will be deposed following the court's decision?
Depositions will include Coventry's Chairman Alan Buerger and other top executives.
What damages is Abacus seeking from Coventry?
Abacus is seeking hundreds of millions in economic and punitive damages for reputational harms.
Why did Abacus file a lawsuit against Coventry?
Abacus claims Coventry engaged in a scheme to spread false information to harm its business.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$ABX Insider Trading Activity
$ABX insiders have traded $ABX stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $ABX stock by insiders over the last 6 months:
- MATTHEW GANOVSKY (Co-Founder and President) sold 2,386 shares for an estimated $20,001
- KEVIN SCOTT KIRBY (Co-Founder and President) sold 2,386 shares for an estimated $20,001
- SEAN MCNEALY (Co-Founder and President) sold 2,386 shares for an estimated $20,001
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$ABX Revenue
$ABX had revenues of $59.4M in Q1 2026. This is an increase of 34.55% from the same period in the prior year.
You can track ABX financials on Quiver Quantitative's ABX stock page.
You can access data on ABX stock through the Quiver Quantitative API.
$ABX Hedge Fund Activity
We have seen 73 institutional investors add shares of $ABX stock to their portfolio, and 67 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ALYESKA INVESTMENT GROUP, L.P. removed 1,176,445 shares (-57.3%) from their portfolio in Q1 2026, for an estimated $9,270,386
- ASHFORD CAPITAL MANAGEMENT INC added 864,900 shares (+inf%) to their portfolio in Q1 2026, for an estimated $6,815,412
- MORGAN STANLEY added 847,166 shares (+408.3%) to their portfolio in Q1 2026, for an estimated $6,675,668
- CITADEL ADVISORS LLC removed 802,112 shares (-90.0%) from their portfolio in Q1 2026, for an estimated $6,320,642
- GOLDMAN SACHS GROUP INC removed 797,187 shares (-65.5%) from their portfolio in Q1 2026, for an estimated $6,281,833
- MARSHALL WACE, LLP removed 402,726 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $3,443,307
- BNP PARIBAS FINANCIAL MARKETS removed 290,147 shares (-97.2%) from their portfolio in Q1 2026, for an estimated $2,286,358
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Full Release
Federal Court Finds Abacus Plausibly Alleged a “scheme to destroy Abacus” and Denies Coventry’s Motion to Dismiss – Depositions, including Chairman Buerger and Coventry Executive Team to Move Ahead
Abacus Alleged a Years-Long Campaign to Systematically Disseminate False and Misleading Information About the Publicly-Traded Company
ORLANDO, Fla., June 26, 2026 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (“Abacus” or the “Company”) (NYSE: ABX), a leader in the alternative asset management space, announced a favorable ruling from the U.S. District Court, Middle District of Florida Orlando Division today in Abacus’s lawsuit against Coventry First LLC, parent company of life settlements provider Coventry Direct (“Coventry”), and its Chairman Alan Buerger. The Court’s decision found that Abacus alleged plausible claims of defamation and anticompetitive conduct and denied Coventry’s Motion to Dismiss. The case will now proceed with depositions of top Coventry executives, including Buerger, whom Abacus believes possess evidence of, in the Court’s words, Coventry’s “scheme to destroy Abacus.” Today’s ruling can be found here .
In July 2025, Abacus sued Coventry and its Chairman Buerger, detailing a concentrated effort by Coventry and Buerger to manipulate market sentiment about its biggest competitor, Abacus, through a slew of false and misleading statements to regulators, auditors, market analysts, customers, investors and the public. This onslaught was designed to cause confusion, concern, and financial injury to Abacus, its clients, and its shareholders. Today’s decision, finding that Abacus has “successfully pled defamation claims,” allows the company to press its suit for economic and punitive damages, and to compensate itself for those reputational harms.
“The court wiped away any impediment to this case going forward and confirmed we’ve presented real, credible, and plausible information about a scheme to destroy Abacus through malfeasance,” said Abacus Global Management CEO Jay Jackson. “Coventry has been losing market share because we offer policyholders better terms and more transparent pricing, so instead of competing, they tried to manipulate markets. Yet while we live in a world filled with people who profit from peddling materially false information, the court today stood up and said this case has merit and is moving ahead.”
Now Abacus will have the chance to uncover the details of Coventry’s attempts to obscure the bottom line of Abacus’s success, as described in the Amended Complaint: “Coventry's false narrative attempts to project its own financial vulnerabilities onto Abacus, but the facts demonstrate otherwise. The market analysts who came to Abacus’ defense . . . recognize the truth: Abacus’ transparent approach is a ray of sunshine in an otherwise beleaguered industry, and that explains its rapid rise.”
Abacus is represented in the lawsuit by Quinn Emanuel Urquhart & Sullivan LLP. Abacus is seeking hundreds of millions in damages, some of which are still accruing, from the harms to its reputation, its customer base, and its relationships with current and potential investors.
The original lawsuit can be read here .
Today’s ruling, which allows the lawsuit to advance, can be found here .
About Abacus
Abacus Global Management (NYSE: ABX) is a leading financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. With a focus on longevity-based assets and personalized financial planning, Abacus leverages proprietary data analytics and decades of industry expertise to deliver innovative solutions that optimize financial outcomes for individuals and institutions worldwide.
For more information, please visit www.abacusgm.com .
Contacts:
Investor Relations
David Jackson – Managing Director of Investor Relations
[email protected]
| (321) 299-0716
Public Relations
[email protected]